Key result
Masked hypertension and sustained hypertension increased the risk of fatal and nonfatal cardiovascular events compared with normotension.
Why the study?
Does daytime ambulatory blood pressure monitoring improve the prediction of fatal and nonfatal cardiovascular events compared to conventional blood pressure measurement in adults?
Does daytime ambulatory blood pressure monitoring improve the prediction of fatal and nonfatal cardiovascular events compared to conventional blood pressure measurement in adults?
Answers are grounded in this paper and cite their sources.
Daytime ambulatory blood pressure monitoring is superior to single-session conventional blood pressure measurements in predicting long-term fatal and nonfatal cardiovascular events, highlighting the risks of masked and white-coat hypertension.
In a not insubstantial number of individuals, ambulatory blood pressure recordings reveal either white-coat hypertension (i.e. a raised conventional blood pressure in the presence of a normal daytime blood pressure) or masked hypertension (i.e. a normal conventional blood pressure but elevated daytime blood pressure) [1–4]. Despite this information, the majority of medical personnel still rely upon conventional blood pressure measurement to diagnose and treat hypertension, and to formulate an estimate of individual cardiovascular risk, based on evidence from large population studies [5]. Unfortunately, a discordance between conventional and ambulatory blood pressure values will lead to the misclassification of many patients, and place the physicians who are advising treatment only on the basis of conventional blood pressure readings at risk of error due to either commission or omission. Such clinical cognitive dissonance has been augmented by the publication of reports illustrating the remarkable variability of blood pressure [6], and demonstrating, in specific populations, the prognostic superiority of ambulatory daytime, night-time or 24-h blood pressure as compared with conventional clinic readings [7–13]. Nonetheless, this technology has been slow to diffuse into routine clinical practice, even though ambulatory blood pressure recordings can be obtained reliably and effectively in the most arduous of conditions [14]. Knowing that such ambulatory data is rarely acquired, an informed patient might legitimately ask whether current practice is truly evidence-based. If ambulatory monitoring of blood pressure were proven to be superior to conventional readings in the prediction of overall cardiovascular event rates in a large, randomly selected population, an obvious resolution to this dilemma would be a broader uptake of this method. In the current issue of the Journal, Hansen et al.[15] test this hypothesis, using a database comprising the largest number of participants and reporting on the largest number of cardiovascular events published to date: the International Database on Ambulatory blood pressure and Cardiovascular Outcomes (IDACO). Their meta-analysis offers new evidence regarding the usefulness of ambulatory monitoring in predicting such events. In developing this database, the investigators identified studies that involved a random population sample, the acquisition at baseline of conventional and ambulatory blood pressures plus data concerning cardiovascular risk factors, and documentation of fatal and nonfatal cardiovascular outcomes during subsequent follow-up [16]. Four such studies, one from Japan and three from Europe, met these criteria. The principal investigators for each study agreed to pool individual subject data from 7030 adults (mean age 56 years; 45% female) followed for a median of 9.5 years. Their goal was to relate conventional and ambulatory blood pressure on enrolment to a primary endpoint combining fatal and nonfatal cardiovascular endpoints. At entry, 21.6% of subjects were receiving antihypertensive therapy. The conventional blood pressure value used for subsequent analysis was the average of two consecutive readings at a single session, acquired using a standard cuff or auscultatory device with subjects either supine or seated, at their home or at an examination centre. Average daytime blood pressure was calculated using several ambulatory blood pressure devices, programmed to obtain readings every 15 or 30 min over 10 h. On the basis of such values (regardless of treatment status), the population was divided into four cohorts: normotension (conventional blood pressure < 140/90 mmHg; daytime ambulatory blood pressure < 135/85 mmHg), white-coat hypertension (conventional blood pressure ≥ 140/90 mmHg; daytime ambulatory blood pressure < 135/85 mmHg), masked hypertension (conventional blood pressure < 140/90 mmHg; daytime ambulatory blood pressure ≥ 135/85 mmHg) and sustained hypertension (conventional blood pressure ≥ 140/90 mmHg; daytime ambulatory blood pressure ≥ 135/85 mmHg). Analysis of outcome was based upon the first cardiovascular event (fatal or nonfatal) experienced. Remarkably, the average conventional (132/79 mmHg) and ambulatory (132/78 mmHg) blood pressure readings were essentially identical. Although 49.4% of subjects were consistently normotensive and 25.4% were consistently hypertensive, there was significant discordance between the conventional and ambulatory values in 25% of the subjects, with white-coat hypertension being present in 10.6% of the population, and an even greater proportion (14.6%) manifesting masked hypertension. The latter findings were not consistent across all four recruitment sites. The prevalence of white-coat hypertension ranged between 6.7 and 17% whereas that for masked hypertension ranged between 11.3 and 20.1%. Nevertheless, these data would suggest that a substantial proportion of a randomly selected population is at risk of misclassification on the basis of isolated conventional blood pressure readings because of either white-coat or masked hypertension. During the course of follow-up, 13.3% of the population (n = 932) died. Of these, 39% deaths could be attributed to adverse cardiovascular events. As anticipated, there was no relationship between blood pressure and total mortality but, in multivariate adjusted continuous analyses, there was a significant predictive relationship between both conventional and ambulatory blood pressure and the 863 recorded fatal plus nonfatal cardiovascular events. Importantly, in fully adjusted models, including both conventional and ambulatory readings, ambulatory blood pressure retained, whereas conventional blood pressure lost, prognostic significance as a predictor for all cardiovascular events. Overall, the predictive value of daytime ambulatory systolic blood pressure was greater than that for daytime ambulatory diastolic blood pressure. This finding should not come as a surprise because the mean age of the participants was near the inflection point at which declining diastolic pressure begins to confer a cardiovascular risk [17]. Risk increased significantly in a stepwise fashion across these four groups (P for trend < 0.0001). Compared with the normotensive population, the diagnosis of masked hypertension conferred a hazard ratio of 1.62 (P < 0.0001) and sustained hypertension conferred a hazard ratio of 1.80 (P < 0.0001). Following adjustment, risks attributable to masked hypertension were not significantly less than that for sustained hypertension. By contrast, aside from a subgroup followed for 12 years, the overall risk arising from white-coat hypertension (1.22) was not significantly greater than that for individuals with normal blood pressure (P = 0.09), but significantly less than that for subjects with sustained hypertension. On the basis of these findings, Hansen et al.[15] proposed that ambulatory blood pressure monitoring should become routine in the risk stratification of patients with hypertension and, in a recently published companion paper from this same database, the same investigators estimated the daytime ambulatory blood pressure thresholds that would confer a 10-year risk of cardiovascular events similar to that for the currently defined optimal, normal and high blood pressure readings obtained using conventional office measurements: 120/80 mmHg (optimal ambulatory blood pressure), 130/85 mmHg (normal blood pressure), and 140/85 mmHg (ambulatory hypertension) [18]. Although these observations and conclusions appear to be intuitive, in that subjects with white-coat hypertension, masked hypertension and sustained hypertension should by definition experience a progressively greater daytime blood pressure burden, if accepted without reservation, the recommendation that ambulatory blood pressure monitoring become routine for risk stratification would have important implications for clinical practice and for governments, institutions or agencies that underwrite its costs. It is therefore important to re-emphasize several key strengths of this investigation. Subjects were recruited at random, a large proportion (70–77%) of those invited agreed to participate in this study, and the findings were consistent across two continents and populations with diverse ethnic backgrounds. By design, this meta-analysis was based upon data from individual subjects, rather than aggregate data from each individual study. The statistical power was enhanced by the large number of subjects recruited, plus the high rate of fatal and nonfatal cardiovascular events. The superiority of ambulatory blood pressure over conventional blood pressure values in predicting subsequent cardiovascular risk was demonstrated in a multivariate analysis, and supported by sensitivity analysis. The 2006 Canadian Hypertension Education Program recommends that conventional blood pressure be taken in the seated position with back support, and that at least two measurements should be taken in the same arm, with the patient in the same position, and the mean recorded. With the exception of patients presenting with hypertensive urgencies, the diagnosis of hypertension requires acquisition of blood pressure using the same method over a minimum of two clinic visits in specific populations, but, more commonly, three to five visits [19]. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure classifies blood pressure on the basis of two or more properly measured seated blood pressure readings on each of two or more office visits [20]. By contrast, in the present comparison, the value for conventional blood pressure was derived from two such readings obtained only at a single session, with some individuals sitting, and some supine. Thus, a skeptic could argue that because the method used to acquire the value for conventional blood pressure does not conform to current guidelines and practice, the hypothesis that daytime ambulatory blood pressure is superior to conventional blood pressure in predicting long-term cardiovascular risk has not been specifically tested. To their credit, the authors acknowledge this as a weakness of their analysis. A better test of their hypothesis would be to compare the conventional blood pressure obtained, according to current recommendations, over a series of clinic visits against the average of several ambulatory daytime recordings (i.e. to account for intrinsic variability in the latter measure) [21]. Such a characterization might diminish the proportion of individuals classified as having either white-coat or masked hypertension. A second major limitation, also noted by these investigators, is that the potential impact of antihypertensive therapy introduced after subject entry was not factored into their analysis. With respect to those receiving pharmacotherapy, there was no consideration of the possibility that the prevalence of masked hypertension may have been inflated by the prescription of agents with relatively short half-lives if ingested before the conventional blood pressure measurement was taken. Finally, the present findings may not apply specifically to other ethnic groups not represented in the IDACO data base. In some studies, high blood pressure at night conferred a risk for subsequent adverse cardiovascular events, which exceeded that of daytime ambulatory blood pressure [9,10,22]. However, we are informed at the outset that the purpose of the present analysis was to compare two measures of daytime blood pressure: conventional and ambulatory. Thus, a subset of masked hypertension, namely individuals with elevated nocturnal blood pressure, whether due to obstructive sleep apnea or another cause of secondary hypertension, was not represented in this meta-analysis. The pursuit of this particular question would represent a natural progression of these investigators' research. As a society, we are willing to contemplate widespread genomic or proteomic subject characterization in pursuit of the concept of ‘individualized medicine’. By contrast, blood pressure measurement is one of the few areas of medical practice where patients in the twenty-first century are assessed almost universally using a methodology developed in the nineteenth. As a consequence, a disconcertingly high proportion of the population may remain at risk for adverse cardiovascular events because their hypertension is neither identified nor treated [23]. In addition, other individuals, labeled inappropriately as having sustained hypertension, may be exposed to excessive therapy with a not insignificant potential for adverse effects. Had 24-h ambulatory blood pressure recordings been acquired in all enrolled subjects, the interpretation of the results of trials such as HOPE [24], LIFE [25] and ASCOT [26] might have been much less ambiguous or controversial. Future technologies capable of estimating ambulatory central aortic pressure might liberate us from the brachial artery waveform. For the present, the IDACO meta-analysis [15] provides compelling evidence in support of the proposition that ambulatory monitoring can augment current clinical practice as a ‘nongenomic’ element of individualized medicine and, by extension, represents a method that should be incorporated routinely into the design of epidemiological or genetic studies and outcome trials. Acknowledgements The author holds the Canada Research Chair in Integrative Cardiovascular Biology and is a Career Investigator of the Heart and Stroke Foundation of Ontario.
No takes yet. Share an insight, caveat, or question.
John S. Floras (2007) conducted an editorial in Hypertension (n=7,030). Masked hypertension vs. Normotension was evaluated on Fatal and nonfatal cardiovascular events (HR 1.62, p=< 0.0001). Masked hypertension and sustained hypertension increased the risk of fatal and nonfatal cardiovascular events compared with normotension.
Synapse has enriched 10 related papers. Consider them for comparative context: